NASDAQ | TSX: ACB
The Expected De-scheduling of Cannabis to Fuel Expansion of the Medical Cannabis Market in Germany
EDMONTON, AB, April 1, 2024 /PRNewswire/ — Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) – a Canadian based leading global medical cannabis company, applauds the German government’s final endorsement of cannabis legalization, marking a significant step forward in bolstering patient access to medical cannabis with the official passing of the Cannabis Act.
This change presents long overdue reform in favour of a more accessible medical cannabis market and commitment to patients. This reform follows the progressive change in leading countries like Canada and will serve as a benchmark for global expansion.
“Germany’s reform brings significant advancements in patient access to medical cannabis and a much-needed liberal approach to cannabis that we have advocated in favour of,”…
